Unglamorous world of 'data infrastructure' driving hot tech M&A market in AI race

Carl Zeiss Meditec (ETR:AFX) reported a weaker-than-expected start to fiscal 2025/26, as management cited currency headwinds, an unfavorable product mix, and challenges in China and the U.S. as key drivers of lower revenue and sharply reduced profitability in the first quarter. Chief Executive Offi Source link

Turkey stocks higher at close of trade; BIST 100 up 1.08% Source link

Canadian National Railway (NYSE:CNI) Reaches New 1-Year Low – Time to Sell? Source link

@Garpal Gumnut maybe a few people asked the same question on Friday and found an answer – it closed up 11.7%. Canaccord Genuity said last June before the annual results came out that it was undervalued. CLG also trades at a modest valuation with a forward FY25 P/E ratio of 6.2x and EV/EBITDA of 3.6x….